1. Market Research
  2. > Cancer Industry

Leukemia Industry, June 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Diagnostics, Cancer, Therapy, Blood Disease, Blood Supply, Pap Smear, Bone Marrow Transplant, Clinical Trial, Cancer Diagnostic, Anti-Infective, In Vitro Diagnostic Reagent, Stem Cell.


 
1-10 of about 300 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

Ewing Sarcoma Global Clinical Trials Review, H1, 2016

Ewing Sarcoma Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Industry report
  • May 2016
  • by Global Data

Ewing Sarcoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Ewing Sarcoma clinical ...

Global Leukemia Partnering 2010 to 2016

Global Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • June 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • June 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Treatment of Chronic Myelogenous Leukemia (CML) - Patent Overview in the years 2011 - 2016

Treatment of Chronic Myelogenous Leukemia (CML) - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in certain blood-forming cells of the bone marrow. In CML, a genetic change takes place in an ...

Treatment of Chronic Lymphocytic Leukemia (CLL) - Patent Overview in the years 2011 - 2016

Treatment of Chronic Lymphocytic Leukemia (CLL) - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

CLL is a condition where you have many abnormal B lymphocytes. The lymphocytes look normal under a microscope, but are abnormal as they do not function properly. The main reason for the build-up of the ...

Treatment of Acute Lymphoblastic Leukemia - Patent Overview in the years 2011 - 2016

Treatment of Acute Lymphoblastic Leukemia - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

This patent report provides a statistical overview of the specified technology/segment for the last five years.The claimed technology in the patent is segmented categorically and is the basis for insights ...

Treatment of Acute Myeloid Leukemia - Patent Overview in the years 2011 - 2016 - Patent Overview in the years 2011 - 2016

Treatment of Acute Myeloid Leukemia - Patent Overview in the years 2011 - 2016 - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Acute lymphocytic leukemia (ALL) is a type of cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made. Acute lymphocytic leukemia is the most common type of cance ...

Treatment of Acute Myeloid Leukemia (AML) - Patent Overview in the years 2011 - 2016

Treatment of Acute Myeloid Leukemia (AML) - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Myelodysplastic syndromes are a group of disorders caused by poorly formed or dysfunctional blood cells. Myelodysplastic syndromes occur when something goes wrong in your bone marrow — the spongy material ...

Global Chronic Lymphocytic Leukemia market 2016-2020

Global Chronic Lymphocytic Leukemia market 2016-2020

  • $ 2 500
  • Industry report
  • June 2016
  • by Infiniti Research Limited

About the Chronic Lymphocytic Leukemia (CLL) Therapeutics Market Cancer that starts from the hematopoietic stem cells of the bone-marrow is referred to as leukemia. Leukemia can be chronic or acute depending ...

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • May 2016
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic ...

About 4 700 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics and Leukemia Statistics

  • January 2014
    265 pages
  • Blood Disease  

    Leukemia  

    Lymphoma  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.